Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Ingevity CorporationNYSE: NGVT

Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026

Depreciation & amortization declines year over year

Q3 FY2026 depreciation & amortization of $20.9M fell 25.4% year over year, behind the -9.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 5.0% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.

Context

  • Depreciation & amortization amounted to 9.1% of revenue in FY2025, up 1.4 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -25.4% toward the trailing-twelve-month pace of -9.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$20.9M-5.0% QoQ
Last fiscal yearDec 2025
$106.4M-1.8% YoY
LTMSep 2026
$93.5M-9.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-25.4%——
1 year-1.8%——
3-year CAGR-0.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
106.4M USD
Year-over-year change
-1.8%
4-year CAGR
-0.8%

Depreciation & Amortization vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -9.8% is the 7th highest of 11, against a peer median of -5.0%.
  • Depreciation & amortization amounts to 8.3% of revenue for NGVT, versus a peer median of 5.0%.
NGVT Competitors
Depreciation & Amortization for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OLNOlin CorporationLTM Jun 2026$498.8M USD-4.4%-4.5%7.4%
FMCFMC CorporationLTM Mar 2026$255.5M USD+42.7%+17.2%7.4%
CCThe Chemours CompanyLTM Jun 2026$238M USD-29.2%+5.3%4.1%
ASHAshland Inc.LTM Jun 2026$191M USD-33.2%-0.6%10.4%
MTXMinerals Technologies Inc.LTM Apr 2026$104.4M USD-1.5%+0.5%4.9%
KWRQuaker Chemical CorporationLTM Sep 2026$101.38M USD+13.4%+5.1%5.0%
NGVTIngevity CorporationLTM Sep 2026$93.5M USD-9.8%-0.7%8.3%
AAUCAllied Gold CorporationLTM Jun 2026$70.96M USD+12.5%+10.7%4.8%
IOSPInnospec Inc.LTM Jun 2026$41.5M USD-5.7%+2.8%2.3%
ELVRElevra Lithium LimitedFY2025A$34.26M AUD-14.7%+79.0%16.5%
SKESkeena Resources LimitedLTM Sep 2026CA$1.6M CAD-60.7%-1.6%—
Peer median (excluding NGVT) —-5.0%+4.0%5.0%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.